The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Finally we have a ticker for Accustem ACMSY
https://www.cnbc.com/quotes/ACMSY
TILS Telegram group link on this tweet.
https://twitter.com/AshfordPlumber/status/1414956509641969664?s=19
There is a telegram group for Accustem already set up.
Link in this tweet for you.
https://twitter.com/AshfordPlumber/status/1414929350688919567?s=19
If it is true... IF.. then Altium and Empery will be leading the lawsuit against them. They were the 2 big investors that sold out in December after the dividend date.
I can really see this as an admin issue with the RNS yesterday. If not, there will be BIG consequences.
I think some people on here are getting confused.
We have not been given a date for listing.
We have not been given a price yet for the shares.
The price will not show on your account of what they are worth until we list on the Nasdaq.
The only potential price it might show will be a nominal value. So possibly 0.01p. We are getting closer to listing but we are still very much in the dark.
Also don't know about you lot but I can't wait for Accustem to be off this board.
Notice of Effectiveness been filed now. We are getting close to Accustem.
"The notice of effectiveness is a public declaration by the Securities and Exchange Commission that a public company's registration statement has been accepted. For shares in a public company to trade on the open market they must be registered by the company"
Reason for the rise in the US. New broker note out from Zacks. $7.50
Oh the leech (Google Sangijuelas) is back again.. How's the shorting going now.?
No... They said they were planning a trial in Brazil.
The pipeline raise didn't include any covid related costs.
The costs of 4D drugs and the area they are going into won't cost as much to do a trial as a mAb.
I don't think you want to go down that path of wrongly accusing tiziana, as last time you had to apologise on stocktwits and on here for your lies.
Please get back to your other companies where you are apparently invested and don't come back as nobody wants to hear from you.
Unfortunately Brazil is a politically driven mess. With death rate of over 500k people and projections of 800k deaths. The president was anti vaxer and anti masks. Putting a trial in this type of environment will be even more challenging because of this.
My best hopes for a covid income for Tiziana is from the UK take home trials. I think we will hear news from this soon. The company heard about this government led initiative back in April on the day it was announced.
I have big hopes for this via the UK trials. Fingers crossed we get the invite and grant.
Absolute game changer to be the worlds first take home nasal monoclonal antibody. This could accelerate the company's pipeline faster than anyone was expecting.
From the spread It looks like a sell. 640,558 at $2.42 bang on 9pm. It's about 0.35% stake in Company
Someone was loading up at end of play today. 67k shares
Ffs.. Can't even write his name without it being filtered.
Renuk*ntla
New signing showed up on LinkedIn.
Venkat Renu****la
Amazing... Lol..
Why have you send me that to my business email? What are you trying to prove? She obviously spoke to me first and then emailed you.
Well I got a phone call from Hana at 17:59 tonight which lasted 4 min 59 seconds. She said I could share that email I received direct from her at 18:02. The email came direct from Hana.
What am I lieing about? I've got no reason to lie. Where as you on the other hand have said you are not invested in this but you still chose to post daily about it. I don't think I have a motive here. We can all see you do.
You don't get a peer review for a P1 trial. I thought you would of given up with this now seeing this response.
Thanks everyone.
SWLC that would be me. That's the email I received after I got a phone call from TILS. I was told I could share the email and that's what I've done.
I have spoken with our management and regulatory consultants and they have informed me that: The INDs for Phase 1 studies with oral and nasal Foralumab formulations were allowed by FDA under INDs submitted by Brigham and Women Hospital (BWH), Harvard Medical School. The IND for the nasal formulation is a commercial type and was transferred to Tiziana Life Sciences on June 10, 2020. The oral IND is a research IND and remains with BWH. This research IND is FDA allowed or "open" to additional clinical studies with the oral formulation using healthy volunteers or patients with M.S. Hence, these INDs were not listed under Tiziana Life Sciences at the time of FDA IND submission (Nasal IND to FDA on June 01, 2018, and Oral IND to FDA July 23, 2019.) The clinical study under the Individual Patient, Expanded Access pathway (filed to FDA on January 14, 2021) and announced recently was granted as an IND to Dr. T. Chitnis, Dept. of Neurology at BWH. Hence, this trial is also under BWH. The COVID-19 study with nasal administration of Foralumab was an exploratory study conducted in Brazil but was not under a US IND. Phase I studies are exempt from a clinicaltrials.gov listing. All clinical investigations are documented with FDA in their respective INDs and are included in annual reports of Tiziana Life Sciences. Every submission under every IND stated herein was made via the Electronic Submission Gateway, and we have unique numbers for every submission. Those numbers track the protocol, and are unique to that protocol, and never used again.
I hope this helps clarify anything you may have been concerned about.
It's the fact nobody listens to you. One day you will understand a conversation is usually 2 ways.. But nobody is listening to you..